Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 404, 809 (20 April 2000) | doi:10.1038/35009255
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
- More Challenges
- Powered by:
nature jobs
Senior Scientific Manager / Chief Scientific Manager for Metabolic Disorder and Cardiavascular Area In Vivo Pharmacology / Biology
- Syngene International
- Bangalore, Karnataka 560099 India
Gastroenterologist
- South Atlanta Medical Clinic, PC (GI Group)
- Atlanta, GA, USA
Open-source work even more vital to genome project than to software
Andreas P. Russ1, Samuel A. J. R. Aparicio2 & Mark B. L. Carlton1
- Wellcome/CRC Institute of Cancer and Developmental Biology, Tennis Court Road, Cambridge CB2 1QR, UK
- Department of Oncology, Wellcome Trust Centre for Molecular Mechanisms in Disease, Addenbrookes Hospital, Cambridge CB2 2XY, UK
We note with dismay and alarm the controversy concerning access, distribution and patenting of the human genome sequence (Nature 404, 317; 2000 & Nature 404, 324; 2000). We wish to point out some analogies between the human genome sequencing efforts and 'open-source' software development, which have implications for the data-release policy of the public sequencing effort.
To read this story in full you will need to login or make a payment (see right).
